Objective: To announce the appointment of Michelle Strange to the Advisory Board of Personify Group as an independent dental hygiene and infection prevention ad
Personify Group, Inc. appointed Michelle Strange, MSDH, RDH, to its Advisory Board as an independent dental hygiene and infection prevention advisor.
Strange has over 25 years of experience in clinical dental hygiene, infection control, education, and independent practice ownership.
In her advisory role, Strange will provide insights on dental hygiene, infection control, clinical workflow, and emerging trends.
Strange owns SmileLogic, an independent dental hygiene practice, and founded platforms focused on education and compliance.
She recently published a book titled Independent by Design, exploring career opportunities for dental hygienists and her journey in practice ownership.
Objective: To investigate the effects of a 20-minute exercise bout and a 90-minute nap on episodic memory performance following 30 hours of wakefulness. Approac
Objective: To examine the association between plasma metabolites in dogs and all-cause mortality. Approach: Study Design: A longitudinal analysis from the Dog A
Objective: To compare the risk of moderate or severe COPD exacerbations between azithromycin and roflumilast in patients with active COPD. Approach: Study Desig
Objective: To evaluate the impact of a diagnostic stewardship program on respiratory culture use in pediatric intensive care units (PICUs). Approach: Study Desi
Objective: To evaluate the efficacy of a new stem cell treatment for patients with aniridia-related keratopathy (ARK). Approach: Study Design: A first-in-human
Objective: To explore how structured light can reshape entoptic phenomena, specifically Boehm's brushes, and to assess its potential as a non-invasive probe of
Entoptic phenomena like Haidinger's and Boehm's brushes allow direct perception of polarized light, revealing interactions between light and retinal tissue.
Researchers transformed Boehm's brushes into complex multi-lobed patterns using spin-orbit-coupled light, enhancing the understanding of retinal health.
The study found that the number of perceived lobes correlates with the topological properties of the incident light, based on orbital angular momentum.
Detection thresholds for the structured-light percept decreased with increasing retinal eccentricity, becoming visible at approximately 1° eccentricity.
The findings suggest potential for structured-light testing as a non-invasive biomarker for assessing retinal integrity and microstructure.
Objective: To examine the association between HLA-A*32:01 and lamotrigine-induced drug reaction with eosinophilia and systemic symptoms (DRESS). Approach: Study
HLA-A*32:01 carriage was found in 41.4% of DRESS cases and 4.1% of lamotrigine-tolerant controls, indicating a strong association with increased DRESS risk.
Current screening practices focus on carbamazepine risk alleles, leaving a gap in identifying lamotrigine-related hypersensitivity risks.
Concurrent acute liver injury occurred in 69.0% of DRESS cases, suggesting hepatic injury is a common manifestation of lamotrigine hypersensitivity.
HLA-A*32:01 screening's clinical utility is uncertain due to low positive predictive values and the allele's presence in only 41.4% of DRESS cases.
Further research is needed to validate HLA-A*32:01 screening across diverse populations and assess its impact on clinical outcomes.
Stimulant-related mortality, particularly from methamphetamine, has significantly increased, marking a fourth wave in the overdose crisis.
No FDA-approved medications exist for treating methamphetamine use disorder, making management particularly challenging.
Contingency management is identified as the most effective psychosocial intervention for stimulant use disorders, yet is underutilized.
The BEAT Meth trial aims to compare usual care with a care navigation intervention that incorporates contingency management principles.
Participants in the study were adults with methamphetamine-related acute care encounters, recruited from Denver Health between April 2023 and September 2024.
Chronic pain (CP) is a major public health issue in the U.S., with healthcare costs exceeding $700 billion and significant burdens on vulnerable populations.
Older adults, particularly those with intersectional identities, experience higher rates of chronic pain and associated health disparities.
Intersectionality and resilience are crucial frameworks for understanding the interplay of risk and protective factors in pain management.
African Americans report greater pain intensity and disability compared to White individuals, highlighting racial disparities in pain outcomes.
Gender differences exist in pain perception, with women generally reporting higher pain intensity and lower pain tolerance than men.